Research in Social and Administrative Pharmacy
Volume 7, Issue 3 , Pages 233-245 , September 2011

Physician-pharmacist collaborative care in dyslipidemia management: The perception of clinicians and patients

  • Lyne Lalonde, Ph.D.

      Affiliations

    • University of Montreal, Faculty of Pharmacy, Montreal, Quebec, Canada
    • Research Team in Primary Care, Centre de santé et de services sociaux de Laval, Cité-de-la-Santé Hospital, 1755 René-Laennec Blvd., Room D-S080, Laval, Quebec H7M 3L9, Canada
    • Sanofi-Aventis Endowment Research Chair in Ambulatory Pharmaceutical Care, Faculty of Pharmacy and Centre de santé et de services sociaux de Laval, Quebec, Canada
    • Corresponding Author InformationCorresponding author. Research Team in Primary Care, Centre de santé et de services sociaux de Laval, Cité-de-la-Santé Hospital, 1755 René-Laennec Blvd., Room D-S080, Laval, Quebec H7M 3L9, Canada. Tel.: +1 450 668 1010x27310; fax: +1 450 975 5089.
    • ,
  • Eveline Hudon, M.D.

      Affiliations

    • Research Team in Primary Care, Centre de santé et de services sociaux de Laval, Cité-de-la-Santé Hospital, 1755 René-Laennec Blvd., Room D-S080, Laval, Quebec H7M 3L9, Canada
    • University of Montreal, Faculty of Medicine, Montreal, Quebec, Canada
    • ,
  • Johanne Goudreau, Ph.D.

      Affiliations

    • Research Team in Primary Care, Centre de santé et de services sociaux de Laval, Cité-de-la-Santé Hospital, 1755 René-Laennec Blvd., Room D-S080, Laval, Quebec H7M 3L9, Canada
    • University of Montreal, Faculty of Nursing, Montreal, Quebec, Canada
    • ,
  • Danielle Bélanger, M.Sc.

      Affiliations

    • Research Team in Primary Care, Centre de santé et de services sociaux de Laval, Cité-de-la-Santé Hospital, 1755 René-Laennec Blvd., Room D-S080, Laval, Quebec H7M 3L9, Canada
    • ,
  • Julie Villeneuve, Ph.D.

      Affiliations

    • Sanofi-Aventis Canada Inc., Laval, Quebec, Canada
    • ,
  • Sylvie Perreault, Ph.D.

      Affiliations

    • University of Montreal, Faculty of Pharmacy, Montreal, Quebec, Canada
    • ,
  • Lucie Blais, Ph.D.

      Affiliations

    • University of Montreal, Faculty of Pharmacy, Montreal, Quebec, Canada
    • ,
  • Diane Lamarre, M.Sc.

      Affiliations

    • University of Montreal, Faculty of Pharmacy, Montreal, Quebec, Canada
    • Ordre des pharmaciens du Québec, Montreal, Quebec, Canada

References 

  1. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications. A cross-national study. JAMA. 1998;279:1458–1462
  2. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462–467
  3. Bourgault C, Davignon J, Fodor G, et al. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study—Observational (CALIPSO). Can J Cardiol. 2005;21:1187–1193
  4. Farahani P, Levine M. Goal attainment for multiple cardiovascular risk factors in community-based clinical practice (a Canadian experience). J Eval Clin Pract. 2009;15:212–216
  5. Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol. 2003;10:101–106
  6. Bluml B, McKenney J, Cziraky M. Pharmaceutical care service and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40:157–165
  7. Paulos CP, Nygren CE, Celedon C, Carcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother. 2005;39:939–943
  8. Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H. Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther. 2004;29:23–30
  9. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149–1155
  10. Community Pharmacy Medicines Management Project Evaluation Team . The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract. 2007;24:189–200
  11. Ibrahim OM, Catania PN, Mergener MA, Supernaw RB. Outcome of cholesterol screening in a community pharmacy. DICP. 1990;24:817–821
  12. Nola KM, Gourley DR, Portner TS, et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc (Wash). 2000;40:166–173
  13. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713–719
  14. Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med. 2004;116:130–133
  15. Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother. 2005;39:1539–1541
  16. Wright H. Pharmacist prescribing: ensuring quality (conference presentation). Royal Pharmaceutical Society of Great Britain. Available at: www.rpsgb.org.uk/pdfs/sciconf070611HW.pdfAccessed 21.05.09
  17. Assemblée Nationale du Québec . Loi modifiant le Code des professions et d'autres dispositions législatives dans le domaine de la santé. Available at: http://www2.publicationsduquebec.gouv.qc.ca/dynamicSearch/telecharge.php?type=5&file=2002C33F.PDFAccessed 10.10.08
  18. Alliance for Pharmaceutical Care . Collaborative drug therapy management: a coordinated approach to patient care. Available at: http://www.pswi.org/professional/patient/drugtherapy.pdfAccessed 12.02.09
  19. Villeneuve J, Lamarre D, Vanier MC, et al. How to help patients manage their dyslipidemia: a primary care physician-pharmacist team intervention. Can Pharm J. 2007;140:300–305
  20. Villeneuve J, Genest J, Blais L, et al. A cluster randomized controlled trial to evaluate an ambulatory primary care management program for patients with dyslipidemia: the TEAM study. CMAJ. 2010;182:447–455
  21. Villeneuve J, Lamarre D, Lussier MT, et al. Physician-pharmacist collaborative care for dyslipidemia patients: knowledge and skills of community pharmacists. J Contin Educ Health Prof. 2009;29:201–208
  22. Giorgi A. The phenomenological movement and research in the human sciences. Nurs Sci Q. 2005;18:75–82
  23. Lee JRE. Prologue: talking organisation. In:  Button G,  Lee JRE editor. Talk and Social Interaction. Clevedon, PA: Multilingual Matters; 1987;
  24. Mucchielli A. Phénoménologique. [analyse] Dictionnaire des méthodes qualitatives en sciences humaines et sociales. Paris: Armand Colin; 1996;
  25. McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular Society . Canadian Cardiovascular Society position statement—recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2006;22:913–927
  26. D'Amour D, Sicotte C, Lévy R. L'action collective au sein d'équipes professionnelles dans les services de santé. Sciences Sociales et Santé. 1999;17:67–92
  27. Moreau A, Dedianne MC, Letrilliart L, LeGoaziou MF, Labarère J, Terra JL. Recherche en médecine générale. Méthode de recherche. S'approprier la méthode du focus group. Rev Prat—Médecine Générale. 2004;18:382–384
  28. Patton MQ. Qualitative Evaluation and Research Methods. 2nd ed.. Newbury Park: Sage Publications; 1990;
  29. Giorgi A. An application of phenomenological method. In:  Giorgi A,  Fischer C,  Murray E editor. Duquesne Studies in Phenomenological Psychology. Vol. II:Pittsburgh: Duquesne University Press; 1975;
  30. Whittemore R, Chase SK, Mandle CL. Validity in qualitative research. Qual Health Res. 2001;11:522–537
  31. Savoie-Zajc L. Acceptation interne (critère d'). In:  Mucchielli A editors. Dictionnaire des méthodes qualitatives en sciences humaines et sociales. Paris: Armand Collin; 1996;
  32. Gladu FP. Perceived shortage of family doctors in Quebec: can we do something about it?. Can Fam Physician. 2007;53:1858–18601871-1853
  33. Association médicale canadienne . Oui aux soins partagés, mais pas à n'importe quel prix. L'actualité médicale. 2007;12:4–5
  34. Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007;41:1962–1970
  35. Pottie K, Farrell B, Haydt S, et al. Integrating pharmacists into family practice teams: physicians' perspectives on collaborative care. Can Fam Physician. 2008;54:1714–1717e1715
  36. Alkhateeb FM, Unni E, Latif D, Shawaqfeh MS, Al-Rousan RM. Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists' responsibilities in West Virginia. J Am Pharm Assoc (2003). 2009;49:797–800
  37. Howard M, Trim K, Woodward C, et al. Collaboration between community pharmacists and family physicians: lessons learned from the Seniors Medication Assessment Research Trial. J Am Pharm Assoc (Wash DC). 2003;43:566–572
  38. McDonough R, Doucette W. Dynamics of pharmaceutical care: developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc (Wash). 2001;41:682–692
  39. D'Amour D, Ferrada-Videla M, San Martin Rodriguez L, Beaulieu MD. The conceptual basis for interprofessional collaboration: core concepts and theoretical frameworks. J Interprof Care. 2005;(19 suppl 1):116–131

 Prior presentations: An abstract of this article was presented to the Association francophone pour le savoir on May 5, 2008, Quebec, Canada; the 96th Annual National Conference of the Canadian Pharmacists Association on June 1, 2008, Victoria, Canada; the IXth World Conference on Clinical Pharmacology and Therapeutics on July 27, 2008, Quebec, Canada; and the 36th North American Primary Care Research Group Annual Meeting on November 18, 2008, Rio Grande, Puerto Rico.

PII: S1551-7411(10)00071-9

doi: 10.1016/j.sapharm.2010.05.003

Research in Social and Administrative Pharmacy
Volume 7, Issue 3 , Pages 233-245 , September 2011

Article Tools